ATI RN
Oncology Questions Questions
Question 1 of 5
A patient with non-Hodgkin lymphoma (NHL) is receiving treatment. What is the most important assessment for the nurse to make in this patient?
Correct Answer: C
Rationale: The correct answer is C: Respiratory function. In a patient with non-Hodgkin lymphoma (NHL), monitoring respiratory function is crucial due to the potential for complications such as pleural effusion or pneumonia. Assessing skin integrity (choice
A) is important but not as critical as monitoring respiratory function in this case. Nutritional status (choice
B) and cognitive function (choice
D) are also important aspects of care but do not take precedence over assessing respiratory function in a patient with NHL undergoing treatment.
Question 2 of 5
As part of chemotherapy education, the nurse teaches a female client about the risk for bleeding and self-care during the period of greatest bone marrow suppression (the nadir). The nurse understands that further teaching is needed if the client makes which statement?
Correct Answer: C
Rationale: The correct answer is C. Taking aspirin is not recommended during periods of bone marrow suppression as it can increase the risk of bleeding. Aspirin is a nonsteroidal anti-inflammatory drug (NSAI
D) that can impair platelet function, further exacerbating the risk of bleeding.
Choices A, B, and D are all appropriate statements for a client at risk for bleeding and undergoing chemotherapy. Blowing the nose gently, being prepared for a platelet transfusion if needed, and monitoring menstrual bleeding are all important aspects of self-care during this period.
Question 3 of 5
The home health care nurse is caring for a client with cancer who is complaining of acute pain. The most appropriate determination of the client's pain should include which assessment?
Correct Answer: A
Rationale: The correct answer is A: The client's pain rating. Pain assessment should primarily rely on the client's self-report for the most accurate determination of pain intensity. Nonverbal cues from the client (choice
B) can provide additional information but should not replace the client's self-report. The nurse's impression of the client's pain (choice
C) may be subjective and less reliable than the client's self-assessment. Pain relief after appropriate nursing intervention (choice
D) is an important outcome but does not replace the initial assessment of the client's pain.
Question 4 of 5
Which of the following management strategies is not included for a patient taking chemotherapeutic drugs?
Correct Answer: C
Rationale: The correct answer is C. Chemotherapy can lead to hair loss, and while using wigs is common, it is not a primary management strategy. The focus should be on limiting exposure to pregnant visitors to prevent harm to the fetus, protecting the client from infections due to a compromised immune system, and administering IV fluids as ordered to maintain hydration levels. Allowing the client to use makeup and wigs is not a primary concern when managing a patient taking chemotherapeutic drugs.
Question 5 of 5
The home health nurse is performing a home visit for an oncology patient discharged 3 days ago after completing treatment for non-Hodgkin lymphoma. The nurse's assessment should include examination for the signs and symptoms of what complication?
Correct Answer: A
Rationale: The correct answer is A: Tumor lysis syndrome (TLS). Tumor lysis syndrome is a potential complication after treatment for certain cancers, including non-Hodgkin lymphoma. The rapid breakdown of cancer cells in response to treatment can lead to metabolic abnormalities, such as hyperkalemia, hyperphosphatemia, hypocalcemia, and hyperuricemia, which can be life-threatening.
Choice B, Syndrome of inappropriate antidiuretic hormone (SIADH), is not typically associated with non-Hodgkin lymphoma treatment.
Choice C, Disseminated intravascular coagulation (DI
C), is more commonly seen in conditions such as sepsis or trauma, not directly related to non-Hodgkin lymphoma treatment.
Choice D, Hypercalcemia, is not a common complication following treatment for non-Hodgkin lymphoma.